Table 2 Carboplatin doses and estimated renal function-based dosing AUC vs actual AUC following pharmacologically guided dosing

From: Adaptive dosing and platinum–DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours

       

Estimated

Achieved

Study

Patient

GFR (ml min−1)

Target AUC (mg ml −1 . min)

Dose modification

Estimated total dose (mg) a

Actual total dose (mg)

AUC b (mg ml −1 .min)

% target AUC

AUC (mg ml −1 .min)

% Target AUC

MMT 98

1

110

20

Day 3

2610

1653

30.3

152

19.6

98

 

2

115

20

Day 3

2720

2921

18.7

94

ND

ND

 

3

104

20

Day 3

2350

1450

32.0

160

19.8

99

 

4

158

20

Day 2

3660

2868

32.6

163

25.2

126

 

5

85

20

None

2090

2090

20.7

104

20.7

104

 

6

71

20

None

1750

1750

21.5

108

ND

ND

 

7

73

20

Day 4

1900

2860

15.4

77

23.7

119

 

8

90

20

Day 4

1565

1243

23.8

119

19.0

95

 

9

21

20

Day 3

575

508

22.5

113

ND

ND

 

10

228

20

Day 3

4785

4071

23.5

118

ND

ND

 

11

30

20

Day 3

750

970

16.9

85

22.1

111

 

12

56

20

Days 3/5

1350

1790

14.8

74

19.3

97

 

13

59

20

Days 3/5

1475

1575

17.9

90

19.5

98

 

14

62

20

Day 4

1500

2500

13.0

65

22.6

113

 

15

97

20

Day 4

2160

2696

15.0

75

18.8

94

 

16

101

20

Day 4

2650

4070

13.0

65

ND

ND

 

17

145

20

Day 4

3400

2664

26.5

133

20.1

101

PNET

18

34

21

None

1026

1026

15.3

73

ND

ND

 

19

104

21

Day 3

3720

2830

27.6

131

ND

ND

 

20

74

21

None

1590

1590

16.7

80

16.7

80

 

21

97

21

Day 3

3141

2554

25.8

123

ND

ND

 

22

124

21

Day 3

3258

2387

30.7

146

20.7

99

 

23

32

21

Day 3

900

1130

14.5

69

19.0

90

 

24

128

21

Day 3

4320

2880

44.7

213

ND

ND

 

25

74

21

None

1608

1608

21.0

100

21.0

100

 

26

42

21

None

1020

1020

20.1

96

20.1

96

 

27

94

21

Day 3

3000

2360

26.7

127

ND

ND

 

28

40

21

None

870

870

20.2

96

20.2

96

     

Range:

MMT 98

13.0–32.6

65–163

18.8–25.2

94–126

      

PNET

14.5–44.7

69-213

16.7–21.0

80–100

  1. aEstimated total dose is based on the day 1 renal function-based dose without modification.
  2. bEstimated total AUC is that which would have resulted if no dose adjustment had been made (based on daily carboplatin clearance values)